List of works - Sebastian Ochsenreither

"Wilms Tumor Protein 1" (WT1) peptide vaccination-induced complete remission in a patient with acute myeloid leukemia is accompanied by the emergence of a predominant T-cell clone both in blood and bone marrow.

scientific article

Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis.

scientific article published on 7 November 2017

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial

scientific article

Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo

scientific article published on 10 March 2020

Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells?

scientific article published on 22 March 2013

Comparison of T-cell receptor repertoire restriction in blood and tumor tissue of colorectal cancer patients.

scientific article

Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen ⬇️

scientific article published on April 23, 2012

Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo

scientific article

Differentiation and gene flow among European populations of Leishmania infantum MON-1.

scientific article

Expression of the stem cell marker nestin in peripheral blood of patients with melanoma.

scientific article published on 24 March 2010

Expression of the stem cell markers nestin and CD133 on circulating melanoma cells

scientific article published on 30 September 2010

Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at Charité.

scientific article published in August 2009

Generation of higher affinity T cell receptors by antigen-driven differentiation of progenitor T cells in vitro

scientific article published on 6 November 2017

Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma

scientific article published on 5 January 2011

Immunotherapy Against Head and Neck Cancer Stem Cells

scientific article published in April 2017

Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies.

scientific article published on 7 November 2013

Long term presence of a single predominant tyrosinase-specific T-cell clone associated with disease control in a patient with metastatic melanoma

scientific article

Melting point assay for the JAK2 V617F mutation, comparison with amplification refractory mutation system (ARMS) in diagnostic samples, and implications for daily routine.

scientific article published on June 2010

Multilocus microsatellite typing (MLMT) reveals genetically isolated populations between and within the main endemic regions of visceral leishmaniasis

scientific article published on 9 January 2007

Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination.

scientific article

Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and O

article

Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations

scientific article published on July 2008

Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells

scientific article published in January 2011

Transferred WT1-Reactive CD8 + T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients ⬇️

scientific article published on February 27, 2013

Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients.

scientific article published on 7 September 2011

List of works by Sebastian Ochsenreither

"Wilms Tumor Protein 1" (WT1) peptide vaccination-induced complete remission in a patient with acute myeloid leukemia is accompanied by the emergence of a predominant T-cell clone both in blood and bone marrow.

Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis.

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial

Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo

Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells?

Comparison of T-cell receptor repertoire restriction in blood and tumor tissue of colorectal cancer patients.

Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen ⬇️

Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo

Differentiation and gene flow among European populations of Leishmania infantum MON-1.

Expression of the stem cell marker nestin in peripheral blood of patients with melanoma.

Expression of the stem cell markers nestin and CD133 on circulating melanoma cells

Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at Charité.

Generation of higher affinity T cell receptors by antigen-driven differentiation of progenitor T cells in vitro

Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma

Immunotherapy Against Head and Neck Cancer Stem Cells

Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies.

Long term presence of a single predominant tyrosinase-specific T-cell clone associated with disease control in a patient with metastatic melanoma

Melting point assay for the JAK2 V617F mutation, comparison with amplification refractory mutation system (ARMS) in diagnostic samples, and implications for daily routine.

Multilocus microsatellite typing (MLMT) reveals genetically isolated populations between and within the main endemic regions of visceral leishmaniasis

Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination.

Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and O

Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations

Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells

Transferred WT1-Reactive CD8 + T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients ⬇️

Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients.